209 related articles for article (PubMed ID: 15516290)
1. Urine concentrations of fentanyl and norfentanyl during application of Duragesic transdermal patches.
Poklis A; Backer R
J Anal Toxicol; 2004 Sep; 28(6):422-5. PubMed ID: 15516290
[TBL] [Abstract][Full Text] [Related]
2. LC-MS/MS analysis of fentanyl and norfentanyl in a fatality due to application of multiple Durogesic transdermal therapeutic systems.
Coopman V; Cordonnier J; Pien K; Van Varenbergh D
Forensic Sci Int; 2007 Jul; 169(2-3):223-7. PubMed ID: 16650707
[TBL] [Abstract][Full Text] [Related]
3. Fentanyl transdermal absorption linked to pharmacokinetic characteristics in patients undergoing palliative care.
Van Nimmen NF; Poels KL; Menten JJ; Godderis L; Veulemans HA
J Clin Pharmacol; 2010 Jun; 50(6):667-78. PubMed ID: 20097932
[TBL] [Abstract][Full Text] [Related]
4. Fentanyl-Norfentanyl Concentrations During Transdermal Patch Application: LC-MS-MS Urine Analysis.
Cummings OT; Enders JR; McIntire GL; Backer R; Poklis A
J Anal Toxicol; 2016 Oct; 40(8):595-600. PubMed ID: 27405369
[TBL] [Abstract][Full Text] [Related]
5. Duragesic transdermal patch: postmortem tissue distribution of fentanyl in 25 cases.
Anderson DT; Muto JJ
J Anal Toxicol; 2000 Oct; 24(7):627-34. PubMed ID: 11043670
[TBL] [Abstract][Full Text] [Related]
6. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.
Huestis MA; Cone EJ; Wong CJ; Umbricht A; Preston KL
J Anal Toxicol; 2000 Oct; 24(7):509-21. PubMed ID: 11043653
[TBL] [Abstract][Full Text] [Related]
7. Determination of fentanyl in human plasma and fentanyl and norfentanyl in human urine using LC-MS/MS.
Huynh NH; Tyrefors N; Ekman L; Johansson M
J Pharm Biomed Anal; 2005 Apr; 37(5):1095-100. PubMed ID: 15862690
[TBL] [Abstract][Full Text] [Related]
8. Urine drug testing of chronic pain patients: licit and illicit drug patterns.
Cone EJ; Caplan YH; Black DL; Robert T; Moser F
J Anal Toxicol; 2008 Oct; 32(8):530-43. PubMed ID: 19007501
[TBL] [Abstract][Full Text] [Related]
9. Fast increase of postmortem fentanyl blood concentrations after transdermal application: A call to careful interpretation.
Reiter A; Mueller A; Otto B; Anders S; Falckenberg M; Iwersen-Bergmann S; Andresen-Streichert H
Forensic Sci Int; 2019 Sep; 302():109896. PubMed ID: 31426021
[TBL] [Abstract][Full Text] [Related]
10. Quantitative measurement of acetyl fentanyl and acetyl norfentanyl in human urine by LC-MS/MS.
Patton AL; Seely KA; Pulla S; Rusch NJ; Moran CL; Fantegrossi WE; Knight LD; Marraffa JM; Kennedy PD; James LP; Endres GW; Moran JH
Anal Chem; 2014 Feb; 86(3):1760-6. PubMed ID: 24354295
[TBL] [Abstract][Full Text] [Related]
11. Urine drug testing of chronic pain patients. III. Normetabolites as biomarkers of synthetic opioid use.
Depriest A; Heltsley R; Black DL; Cawthon B; Robert T; Moser F; Caplan YH; Cone EJ
J Anal Toxicol; 2010 Oct; 34(8):444-9. PubMed ID: 21819788
[TBL] [Abstract][Full Text] [Related]
12. Deaths after intravenous misuse of transdermal fentanyl.
Lilleng PK; Mehlum LI; Bachs L; Morild I
J Forensic Sci; 2004 Nov; 49(6):1364-6. PubMed ID: 15568716
[TBL] [Abstract][Full Text] [Related]
13. In brief: heat and transdermal fentanyl.
Med Lett Drugs Ther; 2009 Aug; 51(1318):64. PubMed ID: 19661852
[TBL] [Abstract][Full Text] [Related]
14. Comparison of plasma fentanyl concentrations by using three transdermal fentanyl patch sizes in dogs.
Egger CM; Duke T; Archer J; Cribb PH
Vet Surg; 1998; 27(2):159-66. PubMed ID: 9525032
[TBL] [Abstract][Full Text] [Related]
15. Variability of transdermal fentanyl metabolism and excretion in pain patients.
Cole JM; Best BM; Pesce AJ
J Opioid Manag; 2010; 6(1):29-39. PubMed ID: 20297612
[TBL] [Abstract][Full Text] [Related]
16. Development of a gas chromatographic-mass spectrometric drug screening method for the N-dealkylated metabolites of fentanyl, sufentanil, and alfentanil.
Valaer AK; Huber T; Andurkar SV; Clark CR; DeRuiter J
J Chromatogr Sci; 1997 Oct; 35(10):461-6. PubMed ID: 9336954
[TBL] [Abstract][Full Text] [Related]
17. Fatal fentanyl intoxication following excessive transdermal application.
Edinboro LE; Poklis A; Trautman D; Lowry S; Backer R; Harvey CM
J Forensic Sci; 1997 Jul; 42(4):741-3. PubMed ID: 9243844
[TBL] [Abstract][Full Text] [Related]
18. Could chest wall rigidity be a factor in rapid death from illicit fentanyl abuse?
Burns G; DeRienz RT; Baker DD; Casavant M; Spiller HA
Clin Toxicol (Phila); 2016 Jun; 54(5):420-3. PubMed ID: 26999038
[TBL] [Abstract][Full Text] [Related]
19. An LC-MS-MS Method for the Analysis of Carfentanil, 3-Methylfentanyl, 2-Furanyl Fentanyl, Acetyl Fentanyl, Fentanyl and Norfentanyl in Postmortem and Impaired-Driving Cases.
Sofalvi S; Schueler HE; Lavins ES; Kaspar CK; Brooker IT; Mazzola CD; Dolinak D; Gilson TP; Perch S
J Anal Toxicol; 2017 Jul; 41(6):473-483. PubMed ID: 28830122
[TBL] [Abstract][Full Text] [Related]
20. Quantitative low-volume assay for simultaneous determination of fentanyl, norfentanyl, and minor metabolites in human plasma and urine by liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Mahlke NS; Ziesenitz V; Mikus G; Skopp G
Int J Legal Med; 2014 Sep; 128(5):771-8. PubMed ID: 24997532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
